Discover how tirzepatide’s dual GIP/GLP-1 “twincretin” mechanism transforms type 2 diabetes treatment. Learn about its powerful HbA1c reduction, significant weight loss, cardiometabolic benefits, and once-weekly peptide design.
Discover how tirzepatide, a dual GIP and GLP‑1 receptor agonist, is transforming type 2 diabetes and obesity treatment with powerful HbA1c reduction and weight loss results that rival bariatric surgery.